Bloomberg Business

Servier’s Experimental Drug Slows Deadly Brain Tumor in Trial

A French drug developer’s experimental therapy slowed the progression of a type of brain cancer by more than 16 months on average, results that could lead to one of the first targeted therapies for the most common form of the tumor in adults younger than age 50.

Astra Drug Improves Survival by Half in Early Stage Lung Cancer

A blockbuster lung cancer drug from AstraZeneca Plc was found to improve survival by more than half in a subset of patients, boosting the company’s ambitions to widen its oncology portfolio across as many groups and indications as possible.

Tata to Build $1.6 Billion Indian EV Battery Plant, Gujarat Says

India’s salt-to-software conglomerate Tata Group signed an agreement with the Gujarat state government to set up a giga-factory for manufacturing lithium-ion cells, with an estimated initial investment of around 130 billion rupees ($1.6 billion).

Close Bitnami banner
Bitnami